Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
Molecules · 19.10.2023 · 28 (20) · 7165
DOI: 10.3390/molecules28207165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 19.10.2023. Verfasst von Giacomo Rossino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Peptides. Die Arbeit wurde bisher 258-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGeneration EU-MUR PNRR 964 Extended Partnership initiative on Emerging Infectious Diseases, NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases.
Abstract (Originalsprache)
Peptides are at the cutting edge of contemporary research for new potent, selective, and safe therapeutical agents. Their rise has reshaped the pharmaceutical landscape, providing solutions to challenges that traditional small molecules often cannot address. A wide variety of natural and modified peptides have been obtained and studied, and many others are advancing in clinical trials, covering multiple therapeutic areas. As the demand for peptide-based therapies grows, so does the need for sustainable and environmentally friendly synthesis methods. Traditional peptide synthesis, while effective, often involves environmentally draining processes, generating significant waste and consuming vast resources. The integration of green chemistry offers sustainable alternatives, prioritizing eco-friendly processes, waste reduction, and energy conservation. This review delves into the transformative potential of applying green chemistry principles to peptide synthesis by discussing relevant examples of the application of such approaches to the production of active pharmaceutical ingredients (APIs) with a peptide structure and how these efforts are critical for an effective green transition era in the pharmaceutical field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
- Department of Health Sciences, University "Magna Graecia", Viale Europa, 88100 Catanzaro, Italy.
ORCID-Profile: Giacomo Rossino, Emanuela Marchese, Matteo Finizio, Massimo Serra, Pasquale Linciano, Simona Collina
Förderung
- NextGeneration EU-MUR PNRR 964 Extended Partnership initiative on Emerging Infectious Diseases
- NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
Zitieren
APA
Rossino, G., Marchese, E., Galli, G., Verde, F., Finizio, M., Serra, M., Linciano, P., & Collina, S. (2023). Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era. Molecules, 28(20), 7165. https://doi.org/10.3390/molecules28207165
Vancouver
Rossino G, Marchese E, Galli G, Verde F, Finizio M, Serra M, et al. Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era. Molecules. 2023;28(20):7165. doi:10.3390/molecules28207165
BibTeX
@article{Rossino2023,
author = {Rossino, Giacomo and Marchese, Emanuela and Galli, Giovanni and Verde, Francesca and Finizio, Matteo and Serra, Massimo and Linciano, Pasquale and Collina, Simona},
title = {Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era},
journal = {Molecules},
year = {2023},
volume = {28},
number = {20},
pages = {7165},
doi = {10.3390/molecules28207165}
}
EUVIMED